盐酸达泊西汀，CAS 登记号 129938-20-1，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸达泊西汀 的 CAS 号：129938-20-1，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Dapoxetine hydrochloride · CAS 129938-20-1 · C21H24ClNO. UNII U4OHT63MRI.
| CAS Registry Number | 129938-20-1 |
|---|---|
| PubChem CID | 71352 |
| Molecular formula | C21H24ClNO |
| IUPAC name | (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine;hydrochloride |
| UNII (FDA) | U4OHT63MRI |
| Molecular Weight | 341.9 |
|---|---|
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 341.1546421 |
| Monoisotopic Mass | 341.1546421 |
| Topological Polar Surface Area | 12.5 |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 337 |
| Reported hazard statements | H302 (97.7%), H319 (93.2%), H413 (88.6%) |
|---|
H302 (97.7%): Harmful if swallowed [Warning Acute toxicity, oral]
H319 (93.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Dapoxetine hydrochloride; 129938-20-1; Dapoxetine HCl; LY210448 HCl; Dapoxetine (as hydrochloride); U4OHT63MRI; RefChem:919662; Priligy; (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride; LY-210448 hydrochloride; Dapoxetine hydrochloride [USAN]; Dapoxetine (hydrochloride); (+)-Dapoxetine hydrochloride; CCG-267940; Dapoxetine hydrochloride, >=98% (HPLC); D03649
CAS 129938-20-1; molecular formula C21H24ClNO; molecular weight — g/mol.
Dapoxetine hydrochloride, 129938-20-1, Dapoxetine HCl, LY210448 HCl, Dapoxetine (as hydrochloride), U4OHT63MRI.
Hazard statements reported: H302, H319, H413.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.